SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

JAGSONPAL PHARMACEUTICALS

BSE: 507789 02 Oct 2025
Healthcare
₹ 222.25
Jagsonpal Pharmaceuticals Limited, specializes in Pharmaceuticals within the Healthcare sector.

JAGSONPAL PHARMACEUTICALS - Share Price & Details

Market Cap
₹1,432
High /Low
328.0 / 158.0
Stock P/E
33.6
Book Value
₹36.1
Dividend Yield
1.16
ROCE
23.0
ROE
₹18.6
Face Value
2.0
PEG Ratio
1.15
EVEBITDA
₹20.3
Debt
9.24
CMP / FCF
24.8
Debt to equity
₹0.04
NP Ann
55.4
High price all time
328.0
Piotroski score
₹6.0
Graham Number
86.3
No. Eq. Shares
6.66
Net CF
₹-1.55
Net profit
60.8
Price to book value
5.95
Interest Coverage
₹55.2
Low price all time
2.4
Industry PE
33.0
Reserves
₹227
Free Cash Flow
₹90.7

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
JAGSONPAL PHARMACEUTICALS LTD.784.37107.95756.121.581,43233.6
KMC SPECIALITY HOSPITALS (INDINANANANA108046.0
LINCOLN PHARMACEUTICALS LTD.1693.38276.751540.6713.82107612.5

Peer Comparison Chart


About JAGSONPAL PHARMACEUTICALS

Jagsonpal Pharmaceuticals Limited,, with Security Code 507789, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

What the Next Quarters Forecast Means for Jagsonpal Pharmaceuticals Limited Investors - Retail Investor Activity & High Return Stock Picks

(28 Sep 2025)
What the Next Quarters Forecast Means for Jagsonpal Pharmaceuticals Limited Investors ✌️【Stock Analysis】✌️ We focus on high-momentum stocks...
Read more →

Jagsonpal Pharmaceuticals Hits Day Low Amid Price Pressure, Drops to Rs 213.25

(26 Sep 2025)
Jagsonpal Pharmaceuticals has seen a significant decline in its stock performance, falling notably today and underperforming its sector.
Read more →

We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned

(18 Sep 2025)
Key Insights Jagsonpal Pharmaceuticals to hold its Annual General Meeting on 24th of September Total pay for CEO Manish...
Read more →

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer

(06 Sep 2025)
Jagsonpal Pharmaceuticals Limited announced the appointment of Amrut Medhekar as ChiefOperating Officer (COO). The newly created role aims...
Read more →

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) Quarterly Results Are Out - Exceptional return forecasts

(14 Aug 2025)
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) Quarterly Results Are Out ✌️【Investment News】✌️ Stop missing opportunities — start profiting...
Read more →

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP

(08 Aug 2025)
Jagsonpal Pharmaceuticals has allotted 66,000 equity shares of Rs. 2/- each under JPL ESOP 2022, to the eligible employees of the Company,...
Read more →